MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

10 Aug 2022 Evaluate
Net sales declined -13.30%  to  Rs. 112.63 million from Rs. 129.91 millions.Net Profit of the company move down -74.43% to Rs. 3.15  millions from Rs. 12.32 millions  in the same quarter last year.A decline of 47.83 millions was observed in the OP in the quarter ended June 2022 from 48.30 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 112.63 129.91 -13.30 112.63 129.91 -13.30 513.91 517.75 -0.74
Other Income 0.01 2.20 -99.55 0.01 2.20 -99.55 0.92 0.79 16.46
PBIDT 47.83 48.30 -0.97 47.83 48.30 -0.97 159.08 177.43 -10.34
Interest 17.63 8.60 105.00 17.63 8.60 105.00 39.93 35.29 13.15
PBDT 30.20 39.70 -23.93 30.20 39.70 -23.93 119.15 142.14 -16.17
Depreciation 23.35 17.87 30.67 23.35 17.87 30.67 74.41 55.91 33.09
PBT 6.85 21.83 -68.62 6.85 21.83 -68.62 44.74 86.23 -48.12
TAX 3.70 9.51 -61.09 3.70 9.51 -61.09 22.71 29.37 -22.68
Deferred Tax 2.56 4.46 -42.60 2.56 4.46 -42.60 15.12 15.79 -4.24
PAT 3.15 12.32 -74.43 3.15 12.32 -74.43 22.03 56.86 -61.26
Equity 148.77 142.05 4.73 148.77 142.05 4.73 142.64 134.19 6.30
PBIDTM(%) 42.47 37.18 14.22 42.47 37.18 14.22 30.95 34.27 -9.67
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..